title: [Immunologic and oncological safety of autologous and allogenic mesenchymal bone marrow stromal cells].
abstract: It is indubitable that autologous transplantation of mesenchymal stromal cells (MSCs) is the golden standard for cell therapy. But also it is still in interest to explore the possibilities of allogeneic MSCs transplantation, because of their special role in lymphopoiesis, particularly in the positive selection of T-lymphocytes.
authors.forename: L B
authors.initials: LB
authors.lastname: Lazebnik
authors.forename: V É
authors.initials: VÉ
authors.lastname: Sagynbaeva
mesh_terms: D001327:Autoimmune Diseases / Q000276:immunology / Q000628:therapy*; D006801:Humans; D045164:Mesenchymal Stem Cell Transplantation / Q000009:adverse effects* / Q000379:methods*; D059630:Mesenchymal Stem Cells / Q000166:cytology / Q000276:immunology; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous